48 projects approved under PLI Scheme for promotion of domestic manufacturing of critical KSMs/DIs/APIs
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
The company received one observation in the Form-483
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Revenue increased 11.4 per cent to Rs. 8,545 crore
3SBio will receive a payment of $1.25 billion. Pfizer will also make a $100 million equity investment in 3SBio
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus
Subscribe To Our Newsletter & Stay Updated